The $560 million company will stop selling products at Woolworths and Priceline and concentrate on selling weight-loss drugs ...

This report covers recent developments in the health sector, including proposed US federal budget cuts affecting scientific ...

The Trump administration this April scrapped a Biden-era proposal that would have required state Medicaid programs and allowed federal Medicare to pay for some GLP-1s for obesity treatment. Instead, ...

Weight loss pills either reduce appetite, boost metabolism or block fat absorption. Most people lose 5% to 10% of their body ...

Sometimes, it makes sense to skip insurance and instead take advantage of a health savings account or flexible savings ...

We recently published a list of What Propelled These 10 Firms’ Double-Digit Gains? In this article, we are going to take a ...

The results were the company's first since its March capital markets day, when it said it would grow top-line production and increase shareholder returns over the next five years. Exxon is ...

Viking is developing what might be a game-changing medication in the segment.

The stock market ended the trading week on a strong note, with all major indices clocking in strong gains, as investors cheered better-than-expected non-farm payrolls last month while digesting more ...

Novo Nordisk shares rose by more than 5% after the Danish weight-loss drug maker said the Food and Drug Administration accepted a new drug application for a pill form of its popular Wegovy injection.

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...